Evidence map›Paper›PMID 22358264›Full record

Trial reportLeukemia2012

Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.

S Daenen, B van der Holt, A W Dekker, R Willemze, A W Rijneveld, B J Biemond, P Muus, A A van de Loosdrecht, H C Schouten, M van Marwijk Kooy and 9 more

Abstract readClinical Trial, Phase IILetterMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Leukemia, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Real-life comparison of posaconazole versus fluconazole for primary antifungal prophylaxis during remission-induction chemotherapy for acute leukemia.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

S Daenen
B van der Holt
A W Dekker
R Willemze
A W Rijneveld
B J Biemond
P Muus
A A van de Loosdrecht
H C Schouten
M van Marwijk Kooy
D A Breems
H Demuynck
J Maertens
P W Wijermans
S Wittebol
E W de Klerk
J J Cornelissen
HOVON
Dutch-Belgian Cooperative Group for Hematological Oncology

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAntineoplastic Combined Chemotherapy ProtocolsFeasibility StudiesFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisProspective StudiesSurvival Rate

Identifiers

PMID22358264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.